TY  - JOUR
AU  - Ray, Kausik K.
AU  - Ference, Brian A.
AU  - Severin, Tania
AU  - Blom, Dirk
AU  - Nicholls, Stephen J.
AU  - Shiba, Mariko H.
AU  - Almahmeed, Wael
AU  - Alonso, Rodrigo
AU  - Daccord, Magdalena
AU  - Ezhov, Marat
AU  - Olmo, Rosa Fernandez
AU  - Jankowski, Piotr
AU  - Lanas, Fernando
AU  - Mehta, Roopa
AU  - Puri, Raman
AU  - Wong, Nathan D.
AU  - Wood, David
AU  - Zhao, Dong
AU  - Gidding, Samuel S.
AU  - Virani, Salim S.
AU  - Lloyd-Jones, Donald
AU  - Pinto, Fausto
AU  - Perel, Pablo
AU  - Santos, Raul D.
PY  - 2022
DO  - 10.5334/gh.1154
SN  - 2211-8160
UR  - http://hdl.handle.net/10668/21657
T2  - Global heart
AB  - Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the...
LA  - en
PB  - Ubiquity press ltd
KW  - cholesterol
KW  - low-density lipoprotein cholesterol prevention
KW  - ASCVD
KW  - lipid lowering therapy
KW  - familial hypercholesterolaemia
KW  - Cardiovascular-disease
KW  - Familial hypercholesterolemia
KW  - Ldl-cholesterol
KW  - Statin therapy
KW  - Risk-factors
KW  - Prevention
KW  - Management
KW  - Metaanalysis
KW  - Individuals
KW  - Evolocumab
TI  - World Heart Federation Cholesterol Roadmap 2022
TY  - research article
VL  - 17
ER  -